Abstract

IntroductionImproving evidence informed decision-making in immunisation is a global health priority and many low and middle-income countries have established National Immunisation Technical Advisory Groups (NITAGs) as independent technical advisory bodies for this purpose. NITAG development and strengthening has received financial and technical support over the past decade, but relatively little evaluation. This study examined NITAGs in six low and middle-income countries (i.e. Armenia, Ghana, Indonesia, Nigeria, Senegal, Uganda), to examine functionality, quality of recommendation development, and integration with national decision-making bodies and processes. MethodsA mixed-method case-series design, used semi-structured interviews, NITAG meeting observations, and document review. Data were analysed thematically. ResultsFive NITAGs had been legally established with terms of reference and appeared well functioning, with Ghana’s in development. All NITAGs had standard operating procedures and nomination procedures to ensure a range of expertise, generally comprising 10–15 core, 1–5 secretariat, and several ex-officio members. Aside from economics, NITAGs reported a wide range of member expertise. Newer NITAGs had particular concerns about funding. Four used formal conflict of interest procedures, although some commented that implications were not always understood. NITAGs valued local data, and limited evidence suggested NITAG presence might reinforce data production through surveillance and local research studies. All observed meetings demonstrated due process and evidence-based decision-making processes were generally followed, with a critical role played by working-group data syntheses and assessments. NITAGs were seen as well integrated with ministry of health (MoH) decision-making and MoH interviewees were positive about NITAG contributions, indicating NITAGs had an important role. Collaboration with other bodies was more limited, but mitigated by NITAG members’ cross-membership in other bodies. ConclusionsNITAGs have an important and valued role within national immunisation decision-making. However, their position remains insecure, with the need for sustainable technical and financial support.

Highlights

  • Improving evidence informed decision-making in immunisation is a global health priority and many low and middle-income countries have established National Immunisation Technical Advisory Groups (NITAGs) as independent technical advisory bodies for this purpose

  • Funded primarily by the Bill & Melinda Gates Foundation, through the Agence de Médecine Préventive (AMP) in collaboration with the International Vaccine Institute (IVI), the SIVAC Initiative provided some degree of support to 43 countries

  • As part of external evaluation of SIVAC (Box 1), a ten-year global initiative to develop and strengthen low and middle-income countries (LMICs) NITAGs [13,14,15], this study examines NITAG implementation, functionality, quality, and integration in Armenia, Ghana, Indonesia, Nigeria, Senegal, and Uganda

Read more

Summary

Introduction

Improving immunisation decision-making and national policy development through better evidence use is a global health priority [1]. The SIVAC Initiative (2008–2017) provided technical support for establishing and strengthening NITAGs in low and middle-income countries [15]. Funded primarily by the Bill & Melinda Gates Foundation, through the Agence de Médecine Préventive (AMP) in collaboration with the International Vaccine Institute (IVI), the SIVAC Initiative provided some degree of support to 43 countries. It worked more extensively in 30 of these countries. Though Ghana’s NITAG was not yet established, it was included as a case because its development received considerable external support, from SIVAC

Study design
Analysis
Functionality
Data collection
Quality
Integration
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call